Eric Karran
Chief Tech/Sci/R&D Officer at Alzheimer’s Research UK
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Adrian N. Hobden | M | 71 |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | - |
Daniel G. Chain | M | 67 |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | 11 years |
Nick Antill | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
David William Donald Cameron | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 7 years |
Rob John Howard | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 6 years |
Caroline van den Brul | F | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 7 years |
Shirley Cramer | F | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Rupert Evenett | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Samuel Jesselson | M | - |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | - |
Michael Jesselson | M | 72 |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | - |
Michael Cooper | M | 63 |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 8 years |
Ruth McKernan | M | 66 |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 6 years |
Christopher Carter | M | 74 |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Richard J. Gnodde | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Giles Dennison | M | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | 7 years |
Parag Phoolchand Saxena | M | 69 |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | - |
David Lionel Mayhew | M | 83 |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Hilary Evans | F | - |
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 13 | 72.22% |
United States | 5 | 27.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Karran
- Personal Network